References
- DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012;33:227–34.
- Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35:161–83.
- Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338–51.
- NICE. Atopic Eczema in Children: Management of Atopic Eczema in Children from Birth Up to the Age of 12 years. London, 2007. Available from guidance.nice.org.uk/cg57. [last accessed 18 Mar 2015].
- Baron SE, Cohen SN, Archer CB. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 2012;37:7–12.
- Williams H, Stewart A, von Mutius E, et al. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121:947–54. e15.
- Watson W, Kapur S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2011;7:S4.
- Deckers IA, McLean S, Linssen S, et al. Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PLoS One. 2012;7:e39803
- Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132–8.
- Baiz N, Dargent-Molina P, Wark JD, et al. Cord serum 25-hydroxyvitamin D and risk of early childhood transient wheezing and atopic dermatitis. J Allergy Clin Immunol. 2014;133:147–53.
- Cheng HM, Kim S, Park GH, et al. Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population. J Allergy Clin Immunol. 2014;133:1048–55.
- Buske-Kirschbaum A, Schmitt J, Plessow F, et al. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2013;38:12–23.
- Wang SS, Hon KL, Kong AP, et al. Vitamin D deficiency is associated with diagnosis and severity of childhood atopic dermatitis. Pediatr Allergy Immunol. 2014;25:30–5.
- Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116–32.
- Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327–49.
- Tan AU, Gonzalez ME. Management of severe atopic dermatitis in children. J Drugs Dermatol. 2012;11:1158–65.
- Slater NA, Morrell DS. Systemic therapy of childhood atopic dermatitis. Clin Dermatol. 2015;33:289–99.
- Walling HW, Swick BL. Update on the management of chronic eczema: new approaches and emerging treatment options. Clin Cosmet Investig Dermatol. 2010;3:99–117.
- Denby KS, Beck LA. Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol. 2012;12:421–6.
- Hon KL, Ma KC, Wong Y, et al. A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic. J Dermatolog Treat. 2005;16:154–7.
- Hon KL, Chan BC, Leung PC. Chinese herbal medicine research in eczema treatment. Chin Med. 2011;6:17
- SATCM. Criteria of Diagnosis and Therapeutic Effect of Diseases and Syndromes in Traditional Chinese Medicine. Nanjing: Nanjing University Press, 1994,.
- CACMS, Evidence-based Guidelines of Clinical Practice in Chinese medicine Specific Disease. Beijing: China Press of Traditional Chinese Medicine, 2011.
- Chen D, Fu X, Fan R, et al. Expert consensus guidelines for diagnosis and treatment of atopic dermatitis with Chinese medicine. Chin J Dermatovenerol Integrated Tradit Western Med. 2013;12:60–1.
- Jiang Y, Jing M, Diao Q, et al. Cluster analysis on syndrome type of TCM in patients with atopic dermatitis. Guangming J Chin Med. 2014;29:1184–6.
- Flower A, Witt C, Liu JP, et al. Guidelines for randomised controlled trials investigating Chinese herbal medicine. J Ethnopharmacol. 2012;140:550–4.
- Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. Int J Nurs Stud. 2013;50:587–92.
- Hon K, Leung T, Ng P, et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Brit J Dermatol. 2007;157:357–63.
- Chen HY, Lin YH, Wu JC, et al. Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: a 1-year follow-up cohort study. J Ethnopharmacol. 2015;159:189–96.
- Gu S, Yang AW, Xue CC, et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev. 2013;9:CD008642.
- Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490
- Tan HY, Zhang AL, Chen D, et al. Chinese herbal medicine for atopic dermatitis: a systematic review. J Am Acad Dermatol. 2013;69:295–304.
- Kuroiwa A, Liou S, Yan H, et al. Effect of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. Int Immunopharmacol. 2004;4:317–24.
- Gu S, Yang AW, Li CG, et al. Topical application of Chinese herbal medicine for atopic eczema: a systematic review with a meta-analysis. Dermatology. 2014;228:294–302.
- Liu J, Mo X, Wu D, et al. Efficacy of a Chinese herbal medicine for the treatment of atopic dermatitis: a randomised controlled study. Complement Ther Med. 2015;23:644–51.
- Yen CY, Hsieh CL. Therapeutic effect of Tzu-Yun ointment on patients with atopic dermatitis: a preliminary, randomized, controlled, open-label study. J Altern Complement Med. 2016;22:237–43.
- Zhang B, Liang B, Wu Y, et al. Analysis of treatment and syndrome differentiation of atopic dermatitis based on data mining. Chin Arch Tradit Chin Med. 2014;32:1020–31.
- Higgins J, Altman D, Sterne J. Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org. [last accessed 30 Jun 2016].
- Schmitt J, Langan S, Stamm T, et al. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol. 2011;131:623–30.
- Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67:1111–17.
- Schmitt J, Apfelbacher C, Spuls PI, et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Invest Dermatol. 2015;135:24–30.
- Schmitt J, Spuls PI, Thomas KS, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134:800–7.